Afecciones renales por COVID-19: Revisión sistemática.

Kidney deseases due to COVID-19: A systemic review.

Autores/as

  • Alejandra G. Félix-Mendoza Universidad de Sonora
  • Gemma V. Flores-Parada Universidad de Sonora
  • Francisco J. González-González Universidad de Sonora
  • Javier A. Picos-Contreras Universidad de Sonora
  • Ana B. Campa-Navarro Universidad de Sonora https://orcid.org/0009-0007-5209-9232

DOI:

https://doi.org/10.59420/remus.6.2021.5

Palabras clave:

SARS-CoV-2, COVID-19, daño renal, ECA2

Resumen

La COVID-19 es una enfermedad infecciosa causada por el virus SARS-COV-2. Los primeros casos fueron identificados y confirmados en diciembre de 2019, en Wuhan, provincia de Hubei, China. Si bien los pulmones son los órganos más afectados por la infección ocasionada por el coronavirus, provocando síndrome de distrés respiratorio agudo (SDRA), neumonía y shock séptico, también se han observado distintas manifestaciones de daño renal, lo cual puede impactar de gran manera en la salud del paciente, especialmente en aquellos que reciben cuidados intensivos. En pacientes hospitalizados se han observado casos de proteinuria, hematuria, insuficiencia renal aguda, entre otras alteraciones de índole renal, sobre todo en pacientes con infección grave. El objetivo del presente artículo es indagar acerca de las alteraciones ocasionadas por SARS-CoV-2 a nivel renal, así como los distintos mecanismos fisiopatológicos implicados.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Fisiología Renal [Internet]. Nefrologiaaldia.org. [citado el 21 de junio de 2021]. Disponible en: https://www.nefrologiaaldia.org/es-articulo-fisiologia-renal-335

Torrescano-de Labra EL, Cupul-Uicab LA, Ramírez-Palacios P, Salmerón J, Muñoz-Aguirre CP, Salazar-Martínez E. Predictors of kidney function in a cohort of Mexican adults. Salud Pública Mex. 2020;62(2):156–65.

Taverna G, Di Francesco S, Borroni EM, Yiu D, Toniato E, Milanesi S, et al. The kidney, COVID-19, and the chemokine network: an intriguing trio. Int Urol Nephrol. 2021;53(1):97–104

Hardenberg J-HB, Luft FC. Covid-19, ACE2 and the kidney. Acta Physiol (Oxf). 2020;230(1):e13539.

Gagliardi I, Patella G, Michael A, Serra R, Provenzano M, Andreucci M. COVID-19 and the kidney: From epidemiology to clinical practice. J Clin Med. 2020;9(8):2506.

Lv W, Wu M, Ren Y, Zeng N, Deng P, Zeng H, et al. Coronavirus disease 2019: Coronaviruses and kidney injury. J Urol. 2020;204(5):918–25.

Datos RTVE. Mapa del coronavirus en el mundo y datos de su evolución [Internet]. RTVE.es. 2021 [citado Jun 11 2021]. Disponible en: https://www.rtve.es/noticias/20210614/mapa-mundial-del-coronavirus/1998143.shtml

COVID-19 Tablero México [Internet]. Conacyt.mx. [citado Jun 11 2021]. Disponible en: https://datos.covid-19.conacyt.mx

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-280.e8.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

Ertuğlu LA, Kanbay A, Afşar B, Elsürer Afşar R, Kanbay M. COVID-19 and acute kidney injury. Tuberk Toraks. 2020;68(4):407–18.

Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339–48.

Chen Y-T, Shao S-C, Hsu C-K, Wu I-W, Hung M-J, Chen Y-C. Incidence of acute kidney injury in COVID-19 infection: a systematic review and meta-analysis. Crit Care. 2020;24(1):346.

Yang X, Tian S, Guo H. Acute kidney injury and renal replacement therapy in COVID-19 patients: A systematic review and meta-analysis. Int Immunopharmacol. 2021;90(107159):107159.

González J, Ciancio G. Early experience with COVID-19 in kidney transplantation recipients: update and review. Int Braz J Urol. 2020;46(suppl.1):145–55. 15.

Farouk SS, Fiaccadori E, Cravedi P, Campbell KN. COVID-19 and the kidney: what we think we know so far and what we don’t. J Nephrol. 2020;33(6):1213–8.

Wang L, Li X, Chen H, Yan S, Li D, Li Y, Gong Z. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China. Am J Nephrol. 2020;51(5):343-348. doi: 10.1159/000507471.

Martinez-Rojas MA, Vega-Vega O, Bobadilla NA. Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol. 2020;318(6):F1454– 62.

Malberti F, Pecchini P, Marchi G, Foramitti M. When a nephrology ward becomes a COVID-19 ward: the Cremona experience. J Nephrol. 2020;33(4):625–8.

Wang H. Maintenance hemodialysis and coronavirus disease 2019 (COVID-19): saving lives with caution, care, and courage. Kidney Med. In press. doi:10.1016/j.xkme.2020.03.003.

Naicker S, Yang C-W, Hwang S-J, Liu B-C, Chen J-H, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020;97(5):824–8.

Goldfarb DS, Benstein JA, Zhdanova O, Hammer E, Block CA, Caplin NJ, et al. Impending shortages of kidney replacement therapy for COVID-19 patients. Clin J Am Soc Nephrol. 2020;15(6):880–2.

Johnson KM, Belfer JJ, Peterson GR, Boelkins MR, Dumkow LE. Managing COVID-19 in renal transplant recipients: A review of recent literature and case supporting corticosteroid-sparing immunosuppression: Review of COVID-19 in renal transplant. Pharmacotherapy. 2020;40(6):517– 24.

Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020;382(25):2475–7.

Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H, et al. Human kidney is a target for novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection [Internet]. bioRxiv. 2020 [citado el 17 de junio de 2021]. p. 2020.03.04.20031120. Disponible en: https://www.medrxiv.org/content/10.1101/2020.03.04.20031120v4

Santoriello D, Khairallah P, Bomback AS, Xu K, Kudose S, Batal I, et al. Postmortem kidney pathology findings in patients with COVID-19. J Am Soc Nephrol. 2020;31(9):2158–67

Kudose S, Batal I, Santoriello D, Xu K, Barasch J, Peleg Y, et al. Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol. 2020;31(9):1959–68.

Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020;144(5):213–21.

Thakar CV. COVID-19 and kidney disease. Adv Chronic Kidney Dis. 2020;27(5):361.

Han X, Ye Q. Kidney involvement in COVID-19 and its treatments. J Med Virol. 2021;93(3):1387–95.

Cohen JB, South AM, Shaltout HA, Sinclair MR, Sparks MA. Renin-angiotensin system blockade in the COVID-19 pandemic. Clin Kidney J. 2021;14(Suppl 1):i48–59.

Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. 2020;16(6):308–10.

Xiong Y, Liu Y, Cao L, Wang D, Guo M, Jiang A, et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg Microbes Infect. 2020;9(1):761–70.

Moeckel GW. Pathologic perspectives on acute tubular injury assessment in the kidney biopsy. Semin Nephrol. 2018;38(1):21–30.

Su H, Yang M, Wan C, Yi L-X, Tang F, Zhu H-Y, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219–27.

Chueh T-I, Zheng C-M, Hou Y-C, Lu K-C. Novel evidence of acute kidney injury in COVID-19. J Clin Med. 2020;9(11):3547.

Kunutsor SK, Laukkanen JA. Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med. 2020;52(7):345–53.

Mabillard H, Sayer JA. Electrolyte disturbances in SARS-CoV-2 infection. F1000Res. 2020;9:587.

Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. 2020;57(3):262–5.

Malieckal DA, Uppal NN, Ng JH, Jhaveri KD, Hirsch JS, the Northwell Nephrology COVID-19 Research Consortium. Electrolyte abnormalities in patients hospitalized with COVID-19. Clin Kidney J. 2021;14(6):1704–7.

Post A, Dullaart RPF, Bakker SJL. Sodium status and kidney involvement during COVID-19 infection. Virus Res. 2020;286(198034):198034.

De Carvalho H, Letellier T, Karakachoff M, Desvaux G, Caillon H, Papuchon E, et al. Hyponatremia is associated with poor outcome in COVID-19. J Nephrol [Internet]. 2021; Disponible en: http://dx.doi.org/10.1007/s40620-021-01036-8.

Descargas

Publicado

2021-08-01

Cómo citar

Félix-Mendoza, A. G., Flores-Parada, G. V., González-González, F. J., Picos-Contreras, J. A., & Campa-Navarro, A. B. (2021). Afecciones renales por COVID-19: Revisión sistemática.: Kidney deseases due to COVID-19: A systemic review. REMUS - Revista Estudiantil De Medicina De La Universidad De Sonora, (6), 20–28. https://doi.org/10.59420/remus.6.2021.5

Número

Sección

Artículos

Métrica

Artículos similares

1 2 3 > >> 

También puede Iniciar una búsqueda de similitud avanzada para este artículo.